High-Dose Glucocorticoids No Better Than Low-Dose for Sudden Hearing Loss

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 10, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Jan. 10, 2024 -- For patients with idiopathic sudden sensorineural hearing loss (ISSNHL), systemic high-dose glucocorticoid therapy is no better than a lower-dose regimen, according to a study published online Dec. 26 in NEJM Evidence.

Stefan K. Plontke, M.D., from the University Medicine Halle in Germany, and colleagues randomly assigned 325 patients with sudden hearing loss of ≥50 dB within seven days of onset to five days of high-dose intravenous prednisolone at 250 mg/day (HD-Pred), high-dose oral dexamethasone (40 mg/d [HD-Dex]), or oral prednisolone (60 mg/day [Pred-Control]) followed by five days of tapering doses.

The researchers found the mean change in the difference in hearing threshold for the three most affected contiguous frequencies from baseline to 30 days was 34.2, 41.4, and 41.0 dB in the HD-Pred, HD-Dex, and Pred-Control groups, respectively. More adverse events related to trial medication were seen in the HD-Pred and HD-Dex than the Pred-Control groups (73 and 76, respectively, versus 46).

"Therapy with systemic high-dose glucocorticoids did not show benefits for patients with sudden sensorineural hearing loss compared with standard lower doses of glucocorticoids but increased the risk of side effects," the authors write. "Further trials are needed to compare glucocorticoid therapy with placebo or -- if this is not feasible -- with further dose de-escalation."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-11 02:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords